Schroder Investment Management Group bought a new stake in LivaNova PLC (NASDAQ:LIVN) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 22,035 shares of the company’s stock, valued at approximately $1,530,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in LIVN. Russell Investments Group Ltd. bought a new position in LivaNova during the second quarter worth about $957,000. Strs Ohio bought a new position in LivaNova during the second quarter worth about $673,000. Bessemer Group Inc. bought a new position in LivaNova during the second quarter worth about $220,000. Schwab Charles Investment Management Inc. lifted its holdings in LivaNova by 91.8% during the second quarter. Schwab Charles Investment Management Inc. now owns 236,427 shares of the company’s stock worth $14,472,000 after acquiring an additional 113,176 shares in the last quarter. Finally, Arizona State Retirement System lifted its holdings in LivaNova by 1.7% during the second quarter. Arizona State Retirement System now owns 18,300 shares of the company’s stock worth $1,120,000 after acquiring an additional 300 shares in the last quarter. 86.07% of the stock is owned by institutional investors.
In other LivaNova news, Director Hugh M. Morrison sold 1,830 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $88.00, for a total transaction of $161,040.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $74.58, for a total value of $74,580.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,830 shares of company stock worth $488,550. Company insiders own 0.28% of the company’s stock.
LivaNova (NASDAQ:LIVN) last released its earnings results on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.76 by $0.17. The business had revenue of $309.70 million for the quarter, compared to the consensus estimate of $301.22 million. LivaNova had a return on equity of 9.33% and a net margin of 4.63%. LivaNova’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.78 earnings per share. research analysts expect that LivaNova PLC will post 3.33 EPS for the current year.
LIVN has been the topic of several recent analyst reports. Canaccord Genuity reiterated a “hold” rating and set a $76.00 target price on shares of LivaNova in a report on Tuesday, November 14th. Needham & Company LLC upgraded LivaNova from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Thursday, September 14th. Piper Jaffray Companies restated an “overweight” rating and issued a $75.00 price target on shares of LivaNova in a report on Tuesday, September 12th. Jefferies Group boosted their price target on LivaNova from $80.00 to $91.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Finally, Zacks Investment Research upgraded LivaNova from a “hold” rating to a “buy” rating and set a $89.00 price target on the stock in a report on Thursday, November 9th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. LivaNova has a consensus rating of “Buy” and a consensus target price of $79.71.
LivaNova Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.